Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly

Autor: Sibel Ocak Serin, Hamide Piskinpasa, Sema Ciftci Dogansen, Osman Pirhan, Asuman Gedikbasi, Yildiz Okuturlar, Mine Adas, Aysegul Akdogan Gemici, Sogol Sadri, Meral Mert, Yasemin Sefika Akdeniz, Ayşe Esen
Rok vydání: 2019
Předmět:
Adult
Blood Glucose
Male
medicine.medical_specialty
Cross-sectional study
Endocrinology
Diabetes and Metabolism

Clinical Biochemistry
030209 endocrinology & metabolism
030204 cardiovascular system & hematology
Biochemistry
Carotid Intima-Media Thickness
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Endocrinology
Diabetes mellitus
Internal medicine
Acromegaly
medicine
Humans
In patient
Insulin-Like Growth Factor I
Nicotinamide Phosphoribosyltransferase
Glycemic
Glycated Hemoglobin
business.industry
Human Growth Hormone
Biochemistry (medical)
Case-control study
General Medicine
Middle Aged
medicine.disease
Atherosclerosis
Prognosis
Cross-Sectional Studies
Intima-media thickness
chemistry
Case-Control Studies
Cytokines
Female
Glycated hemoglobin
business
Biomarkers
Follow-Up Studies
Zdroj: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 51(10)
ISSN: 1439-4286
Popis: The purpose of the study was to compare serum visfatin levels between patients with acromegaly and healthy controls and to evaluate the relationships between visfatin levels and epicardial fat thickness (EFT), carotid intima media thickness (cIMT), and ankle brachial index (ABI). We conducted a cross-sectional case-control study of 54 patients with acromegaly (37 females and 17 males) and 34 healthy controls (22 females and 12 males). Serum visfatin was measured by ELISA. Acromegalic and control participants and those with active or controlled acromegaly were compared with respect to their serum visfatin, clinical and metabolic parameters, EFT, cIMT, and ABI. Linear correlation was used to identify associations between these parameters and visfatin in all participants. Serum visfatin and glycated hemoglobin (HbA1c) were higher in the acromegaly group than in the control group (p
Databáze: OpenAIRE